PharmaVoice

FEBRUARY 20, 2024

A significant growth is predicted for both AI and IoT in healthcare. By 2030, the AI market is expected to reach $187.95 billion USD, while the IoT market is projected to climb even higher to $312.7 billion USD.

Marketing 104

Marketing Healthcare Healthcare 104

Healthcare Success

JANUARY 2, 2024

Now that the holidays have drawn to a close, it’s time to return to your 2024 marketing plan and make adjustments that ensure your business is taking advantage of the latest trends in healthcare marketing to reach patients and HCPs more effectively and make a lasting impression.

Healthcare 78

Healthcare Healthcare Marketing Healthcare Provider 78

Pharmaceutical Technology

SEPTEMBER 15, 2023

A new report found that the Remote Patient Monitoring (RPM) sector will grow, since the pandemic revealed the benefits of remote healthcare.

Patients 52

Patients Marketing Healthcare Healthcare 52

LEVO Health

MAY 8, 2024

As healthcare practices strive to navigate the complexities of patient needs and preferences, the importance of fostering robust patient engagement strategies cannot be overstated. The Importance of Patient Engagement Personalization for patients is a key driver of improved healthcare outcomes.

Healthcare 52

Healthcare Healthcare Patients Healthcare Provider 52

Clarify Health

OCTOBER 3, 2023

Despite the rapid adoption of digital technology in other industries, healthcare has been a bit slower to transform. This shift in healthcare focuses on treating patients more like consumers , giving them more control and options in their healthcare decisions.

Healthcare 59

Healthcare Healthcare Patients Side effects 59

Medico Reach

JUNE 29, 2022

You need strategic market research to validate your credibility as a healthcare company. For this reason, you need the help of reliable healthcare market research companies. Fortunately, you can take advantage of our curated list of the top 25 healthcare market research companies. Reckner Healthcare. Lucid Health.

Healthcare 98

Healthcare Healthcare Marketing Specialization 98

MedCity News

FEBRUARY 15, 2023

Analysts predict that disruptors could own as much as 30% of the $260 billion primary care market by 2030.

Healthcare 112

Healthcare Healthcare Marketing Medical 112

PM360

NOVEMBER 29, 2022

The White House’s recent Health Sector Climate Pledge brought together hospitals and healthcare companies that committed to reduce greenhouse gas emissions 50% by 2030. Committing to Sustainability Practices in Healthcare. It is a long overdue effort to promote sustainability and combat climate change.

Healthcare 98

Healthcare Healthcare Manufacturing Pharmaceutical 98

European Pharmaceutical Review

JULY 5, 2022

In the same statement, Pfizer also announced it has signed a pledge by the US Department of Health and Human Services (HHS) that calls on US healthcare system stakeholders such as hospitals, health systems, payers, suppliers and pharmaceutical companies to reduce GHG emissions and build a more climate resilient healthcare infrastructure.

Government 111

Government Healthcare Healthcare Pharmaceutical 111

European Pharmaceutical Review

DECEMBER 13, 2022

It will be a base for approximately 3,000 people, including GSK’s global leadership team and teams for research and development, supply chain, commercial operations, corporate functions and ViiV Healthcare. It also offers close proximity to GSK’s collaboration partners including the Francis Crick Institute and King’s College London.

Healthcare 105

Healthcare Healthcare Pharmaceutical 105

Clarivate

AUGUST 17, 2022

Grace tells us about her experience as a physician and discusses healthcare literacy and education at the point of care. Also listed as a target is reducing premature deaths from non-communicable diseases by one third by 2030. The post Improving patient access and healthcare literacy [PODCAST] appeared first on Clarivate.

Healthcare 52

Healthcare Healthcare Patients Physicians 52

Pharmaceutical Technology

MAY 29, 2023

GlobalData’s Blockchain Market Size, Share, Trends, and Segment Forecast to 2030 report offers insights on application of blockchain in healthcare and other key sectors. For further understanding of GlobalData's Blockchain Market Size, Share, Trends, and Segment Forecast to 2030 buy the report here.

Pharmaceutical 52

Pharmaceutical Marketing Competition Medicine 52

World of DTC Marketing

NOVEMBER 3, 2020

Obesity, lack of exercise, and too much salt are all contributing to a myriad of health issues that are going to drive up healthcare costs. A prestigious team of medical scientists has projected that by 2030, nearly one in two adults will be obese, and nearly one in four will be severely obese.

Insurance 190

Insurance Healthcare Healthcare Physicians 190

European Pharmaceutical Review

JANUARY 22, 2024

million by 2030, according to a report by ResearchAndMarkets. Between 2023 to 2030, this represents a CAGR of 15.13 As such, the report predicted that E&L testing services will continue to “play a pivotal role in ensuring the safety and quality of healthcare products”, especially up to 2030.

Marketing 52

Marketing Safety Medicine Pharmaceutical 52

Nixon Gwilt Law

NOVEMBER 14, 2024

Here’s a closer look at the APCM codes in the Final Rule and what they could mean for healthcare innovators and primary care providers. The Bottom Line As CMS moves closer to its goal of having all Medicare beneficiaries in accountable care models by 2030, the APCM codes could set the stage for a new era in value-based care.

Physicians 52

Physicians Management Healthcare Healthcare 52

World of DTC Marketing

AUGUST 21, 2020

An analysis is predicting that by 2030, 48.9% What this means in real terms is that a lot of money is going to be needed for healthcare and that our reliance on nonprescription drugs is going to increase in lieu of exercising and eating healthy. of adults in the United States will be obese and 24.2% will be severely obese. .

Insurance 238

Insurance Physicians Healthcare Healthcare 238

World of DTC Marketing

DECEMBER 18, 2020

Yet the media continues to blame pharma for our healthcare woes while a new analysis is predicting that by 2030, 48.9% It’s easy to blame pharma with their excessive CEO salaries and high profits but the reality is that spending on new drugs continues to be a small part of healthcare spending. will be severely obese.

Pharma 155

Pharma Prescription Media Healthcare 155

PharmaTech

OCTOBER 22, 2023

According to Grandview Research, the hybrid and decentralized clinical trial (DCT) market will be worth more than 12 billion dollars by 2030. This guide serves as a roadmap for pharmaceutical companies, researchers, healthcare professionals, and anyone interested in understanding the fundamentals of decentralized clinical trials.

Electronics 40

Electronics Recruitment Healthcare Healthcare 40

World of DTC Marketing

MAY 16, 2022

Sales of Mounjaro could approach $14 billion annually by 2030. If Lilly can build a relationship with patients based on their need to help them lose weight and keep it off, it can make a bold step into a new era in healthcare where pharma becomes a trusted partner. This is going to be a major change in public health.”

Food and Drug Administration 218

Food and Drug Administration Side effects Pharma Patients 218

Contrarian Sales Techniques

NOVEMBER 18, 2024

This surge is driven by a rising global demand for Halal-certified products, including medicines and healthcare items ([link] The Malaysian government has supported this growth through initiatives like the Halal Industry Master Plan 2030, aiming to position Malaysia as a global leader in the Halal sector [ reference ].

Medicine 40

Medicine Food Pharmaceutical Pharmaceutical Sales 40

European Pharmaceutical Review

DECEMBER 2, 2022

Increase awareness of the benefits of adult vaccination among citizens and healthcare professionals. healthcare budget on?immunisation, Vaccines Europe states that the actions must be addressed to ensure the European Beating Cancer Plan and the Immunization Agenda 2030 are met. percent of their?healthcare

Healthcare 98

Healthcare Healthcare Competition Pharmaceutical 98

European Pharmaceutical Review

JANUARY 27, 2023

This is an effort which aims to improve access and address barriers to quality healthcare for 30 million people living in limited-resource settings annually, by 2030.

Distribution 105

Distribution Transportation Medicine Medical 105

World of DTC Marketing

JULY 17, 2022

A Harvard study found that almost half of Americans are expected to be obese by 2030, accounting for up to 18 percent of healthcare spending on related conditions, ranging from heart disease and stroke to osteoarthritis. . Wegovy arrived on the market amid a global obesity crisis. So far, the data for Wegovy looks excellent.

Side effects 209

Side effects Doctors Insurance Prescription 209

Contrarian Sales Techniques

OCTOBER 19, 2024

This is all part of the bigger picture to boost domestic investments and create jobs – 900,000 to be exact by 2030. And Our All Time Favorite: Healthcare & Pharmaceuticals Let’s touch a bit on healthcare in the Budget 2025. Are you feeling the positive vibes from this boost in healthcare spending? What about you?

Medical sales 52

Medical sales Medical sales reps Government Ethics 52

European Pharmaceutical Review

AUGUST 19, 2022

In addition, investigators cited the increasing geriatric patient population, growing consumption of medicines, rising healthcare expenditure, improving healthcare infrastructure in emerging markets and mounting pressure to reduce healthcare costs as other factors driving market growth. Within the $130.2

Manufacturing 98

Manufacturing Marketing Pharma Healthcare 98

World of DTC Marketing

JANUARY 7, 2021

By 2030, low retention will, on average, cost the US $430 billion annually. I do not doubt that eventually, Congress will act to bring down rising healthcare costs, and that effect could be profound on big pharma. Here are some troubling employee retention statistics: 65% of employees think they can find a better position elsewhere.

Pharma 215

Pharma Side effects Distribution Consulting 215

European Pharmaceutical Review

NOVEMBER 3, 2022

Align new trials to companies’ decarbonisation pathway and put in place emission targets for clinical trials by no later than 2030. The Task Force has published whitepapers outlining recommendations and scalable actions for Decarbonising Healthcare Supply Chains and The Digital Solution for Sustainability in Clinical Research.

Pharma 98

Pharma Government Pharmaceutical Healthcare 98

Medico Reach

MARCH 24, 2023

As a result, a global approach to healthcare has emerged continually over the years. This global approach to healthcare is known as precision medicine which has emerged in treatments like immunotherapy. It is further expected to reach USD 14,505 million in 2030. billion by 2030. billion , growing at a CAGR of 10.2%

Marketing 52

Marketing Medicine Healthcare Healthcare 52

Medico Reach

MARCH 24, 2023

As a result, a global approach to healthcare has emerged continually over the years. This global approach to healthcare is known as precision medicine which has emerged in treatments like immunotherapy. It is further expected to reach USD 14,505 million in 2030. billion by 2030. billion , growing at a CAGR of 10.2%

Marketing 52

Marketing Medicine Healthcare Healthcare 52

Clarify Health

FEBRUARY 8, 2024

It is no exaggeration that the American healthcare industry faces a looming crisis: an increasing number of older adults with complex healthcare needs. is just 13 percent but accounts for more than a third of healthcare expenditures. Today, the 65-and-older population in the U.S. million , up from 63.6 million in 2022.

Healthcare 52

Healthcare Healthcare Specialization Insurance 52

European Pharmaceutical Review

DECEMBER 15, 2022

Lilly’s 30×30 initiative aims to improve access to quality healthcare for 30 million people living in limited-resource settings, annually, by 2030. EVA Pharma anticipates beginning distribution of the African-made insulin products within 18 months.

Pharma 97

Pharma Distribution Manufacturing Pharmaceutical 97

pharmaphorum

JANUARY 24, 2023

In this final instalment of IQVIA EMEA Thought Leadership’s Nine for 2023 three-part series, focusing on issues that will change the direction of healthcare and the pharmaceutical industry this year, three key competitive issues for pharmaceutical companies in 2023 are assessed.

Medicine 92

Medicine Healthcare Healthcare Pharma 92

Clarify Health

OCTOBER 12, 2023

After two decades, healthcare is still working to find a better way to reward clinicians for the quality and efficiency of the care they provide rather than for the volume of patients treated. Collaboration between health plans and healthcare providers is crucial in achieving better outcomes.

Healthcare Provider 59

Healthcare Provider Insurance Healthcare Healthcare 59

Pharmaceutical Technology

MARCH 31, 2023

This also demonstrates our confidence in the investment climate in Kenya and the importance of utilising mRNA technology to build resilience in healthcare security in Africa.” The company is also committed to establishing mRNA manufacturing facilities in Australia, Canada, the US and the UK.

Manufacturing 105

Manufacturing Government Medicine Healthcare 105

Pharmaceutical Technology

JULY 21, 2022

As part of ESG (Environmental, Social, and Governance), the social good delivered by robust healthcare systems are at the core of healthy populations. The Covid-19 pandemic has demonstrated how vital patient access to quality and affordable healthcare is for patients all over the world. Climate change and ESG.

Government 52

Government Healthcare Healthcare Pharma 52

European Pharmaceutical Review

JUNE 27, 2022

Stella Kyriakides, Commissioner for Health and Food Safety stated: “Non-communicable diseases represent 80 percent of the disease burden in the EU, placing considerable pressure on our healthcare systems. Today’s initiative is an important step to continue tackling them in a systematic and comprehensive way. Did you know, 1.7

Medicine 110

Medicine Healthcare Healthcare Government 110

Medico Reach

FEBRUARY 8, 2023

Hence, looking closer at the future trends in pharma industry only makes sense for businesses to stay afloat in the healthcare market. from 2022 to 2030, the pharma industry will reach USD 9,241.34 million by 2030. from 2023 to 2030. Poised to grow at a CAGR of 29.4% billion in 2022 and will expand at a CAGR of 10.3%

Pharma 52

Pharma Medicine Marketing Prospecting 52